ECSP16086247A - (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina - Google Patents
(s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicinaInfo
- Publication number
- ECSP16086247A ECSP16086247A ECIEPI201686247A ECPI201686247A ECSP16086247A EC SP16086247 A ECSP16086247 A EC SP16086247A EC IEPI201686247 A ECIEPI201686247 A EC IEPI201686247A EC PI201686247 A ECPI201686247 A EC PI201686247A EC SP16086247 A ECSP16086247 A EC SP16086247A
- Authority
- EC
- Ecuador
- Prior art keywords
- pirlindole
- pharmaceutically acceptable
- acceptable salts
- medicine
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
(S)-pirlindole o sus sales farmacéuticamente aceptables, así como composiciones farmacéuticas que comprenden el mismo para uso en el tratamiento terapéutico y prevención del dolor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PT2014/000029 WO2015171005A1 (en) | 2014-05-09 | 2014-05-09 | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP16086247A true ECSP16086247A (es) | 2017-02-24 |
Family
ID=50819931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201686247A ECSP16086247A (es) | 2014-05-09 | 2016-11-09 | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US9814712B2 (es) |
| EP (1) | EP3057589B1 (es) |
| JP (1) | JP6768520B2 (es) |
| KR (1) | KR102298676B1 (es) |
| CN (1) | CN106456637B (es) |
| AU (1) | AU2014393490B2 (es) |
| CA (1) | CA2948598C (es) |
| CY (1) | CY1119532T1 (es) |
| DK (1) | DK3057589T3 (es) |
| EC (1) | ECSP16086247A (es) |
| ES (1) | ES2649492T3 (es) |
| HR (1) | HRP20171651T1 (es) |
| HU (1) | HUE035071T2 (es) |
| IL (1) | IL248855B (es) |
| LT (1) | LT3057589T (es) |
| MA (1) | MA39447B1 (es) |
| MX (1) | MX368734B (es) |
| NO (1) | NO3057589T3 (es) |
| NZ (1) | NZ726132A (es) |
| PH (1) | PH12016502233A1 (es) |
| PL (1) | PL3057589T3 (es) |
| PT (1) | PT3057589T (es) |
| RS (1) | RS56591B1 (es) |
| RU (1) | RU2695647C2 (es) |
| SA (1) | SA516380264B1 (es) |
| SI (1) | SI3057589T1 (es) |
| SM (1) | SMT201700519T1 (es) |
| TN (1) | TN2016000498A1 (es) |
| UA (1) | UA118474C2 (es) |
| WO (1) | WO2015171005A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2988983T3 (es) * | 2014-05-09 | 2024-11-22 | Tecnimede Sociedade Tecnico Medicinal S | Sales de mandelato de enantiómeros de pirlindol para uso en medicina |
| SI3054950T1 (sl) | 2014-05-09 | 2017-12-29 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | (r)-pirindol in njegove farmacevtsko sprejemljive soli za uporabo v medicini |
| EP3392250A1 (en) | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives |
| EP3392251A1 (en) | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Process for the preparation of pirlindole enantiomers and its salts |
| MX2018011142A (es) | 2018-09-13 | 2019-10-10 | Federico Amezcua Amezcua | Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona. |
| EP3900716A1 (en) | 2020-04-21 | 2021-10-27 | Dompe' Farmaceutici S.P.A. | Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use |
| CN117717546B (zh) * | 2023-10-20 | 2026-06-12 | 四川大学华西医院 | 一种吲哚类衍生物在制备预防和/或治疗疼痛的药物中的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006504795A (ja) * | 2002-10-03 | 2006-02-09 | サイプレス バイオサイエンス， インコーポレイテッド | 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬 |
| KR20050101537A (ko) * | 2002-12-24 | 2005-10-24 | 뉴로켐 (인터내셔널) 리미티드 | 베타-아밀로이드 관련 질환의 치료를 위한 치료 제제 |
| KR20060117909A (ko) * | 2003-09-15 | 2006-11-17 | 벡투라 리미티드 | 폐 흡입에 의한 조루 치료용 제약학적 조성물 |
| EP1688161A1 (en) * | 2004-11-02 | 2006-08-09 | Switch Biotech Aktiengesellschaft | Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
| ES2988983T3 (es) * | 2014-05-09 | 2024-11-22 | Tecnimede Sociedade Tecnico Medicinal S | Sales de mandelato de enantiómeros de pirlindol para uso en medicina |
-
2014
- 2014-05-09 UA UAA201611332A patent/UA118474C2/uk unknown
- 2014-05-09 TN TN2016000498A patent/TN2016000498A1/en unknown
- 2014-05-09 NZ NZ726132A patent/NZ726132A/en unknown
- 2014-05-09 SI SI201430462T patent/SI3057589T1/sl unknown
- 2014-05-09 JP JP2016567545A patent/JP6768520B2/ja active Active
- 2014-05-09 RU RU2016148183A patent/RU2695647C2/ru active
- 2014-05-09 WO PCT/PT2014/000029 patent/WO2015171005A1/en not_active Ceased
- 2014-05-09 MA MA39447A patent/MA39447B1/fr unknown
- 2014-05-09 NO NO14726444A patent/NO3057589T3/no unknown
- 2014-05-09 ES ES14726444.4T patent/ES2649492T3/es active Active
- 2014-05-09 DK DK14726444.4T patent/DK3057589T3/da active
- 2014-05-09 HU HUE14726444A patent/HUE035071T2/en unknown
- 2014-05-09 HR HRP20171651TT patent/HRP20171651T1/hr unknown
- 2014-05-09 LT LTEP14726444.4T patent/LT3057589T/lt unknown
- 2014-05-09 AU AU2014393490A patent/AU2014393490B2/en active Active
- 2014-05-09 PT PT147264444T patent/PT3057589T/pt unknown
- 2014-05-09 RS RS20171094A patent/RS56591B1/sr unknown
- 2014-05-09 CA CA2948598A patent/CA2948598C/en active Active
- 2014-05-09 EP EP14726444.4A patent/EP3057589B1/en active Active
- 2014-05-09 CN CN201480078727.XA patent/CN106456637B/zh active Active
- 2014-05-09 US US15/309,899 patent/US9814712B2/en active Active
- 2014-05-09 KR KR1020167031373A patent/KR102298676B1/ko active Active
- 2014-05-09 SM SM20170519T patent/SMT201700519T1/it unknown
- 2014-05-09 PL PL14726444T patent/PL3057589T3/pl unknown
- 2014-05-09 MX MX2016014699A patent/MX368734B/es active IP Right Grant
-
2016
- 2016-11-09 SA SA516380264A patent/SA516380264B1/ar unknown
- 2016-11-09 EC ECIEPI201686247A patent/ECSP16086247A/es unknown
- 2016-11-09 IL IL248855A patent/IL248855B/en active IP Right Grant
- 2016-11-09 PH PH12016502233A patent/PH12016502233A1/en unknown
-
2017
- 2017-10-30 CY CY20171101123T patent/CY1119532T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024013963A (es) | Un antagonista de il-4r util para el tratamiento o la prevencion del asma | |
| MX2021008113A (es) | Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma. | |
| CY1125326T1 (el) | Προαιρετικως συντηγμενα ετεροκυκλυλο- υποκατεστημενα παραγωγα πυριμιδινης χρησιμα για τη θεραπευτικη αγωγη φλεγμονωδων, μεταβολικων, ογκολογικων και αυτοανοσων ασθενειων. | |
| MX378273B (es) | Compuestos activos hacia bromodominios. | |
| NI201600115A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
| CL2016001609A1 (es) | Composiciones farmacéuticas que comprenden azd9291. | |
| MX386752B (es) | Agonistas del receptor farnesoide x y usos de los mismos. | |
| CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
| CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
| ES3057783T3 (en) | Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases | |
| MX2016016583A (es) | Derivados de indolizina como inhibidores de fosfoinositido-3 cinasas. | |
| CL2016001918A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
| MX2016007410A (es) | Derivados del isocromeno como inhibidores de las fosfoinositido-3 cinasas. | |
| DOP2016000254A (es) | Formulaciones farmeceuticas de inhibidor de la quinasa pan-raf, procedimientos para su preparacion, y metodos de uso. | |
| CR20160529A (es) | Composiciones farmacéuticas para tratar enfermedades infecciosas | |
| CY1119532T1 (el) | (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| CL2018003338A1 (es) | Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant. | |
| MX384447B (es) | Composiciones farmacéuticas y usos dirigidos a los trastornos del almacenamiento lisosomal. | |
| ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| UY36732A (es) | Piridin pirazinonas novedosas como inhibidores de bromodominios de la familia bet | |
| IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. | |
| MX2017003469A (es) | Inhibidores macrociclicos de cinasa rip2. | |
| MX2019009909A (es) | Composiciones farmaceuticas para terapia de combinacion. | |
| CL2015003211A1 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio. | |
| AR106415A1 (es) | Composición farmacéutica para el tratamiento del dolor |